AzTrials
AzTrials

Periodontal DiseasesQ_ITANCT07461753

Development, Validation, and Assessment of the Diagnostic Accuracy of a Questionnaire for Periodontitis Screening

An observational study of Periodontal Diseases and Periodontitis, run by Azienda Unità Sanitaria Locale (A.U.S.L.) Ferrara, Italy.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The present study aims at validating the Italian version of one of the most widely used epidemiological questionnaires for periodontitis screening: the CDC/AAP questionnaire [hereafter referred to as the CDC/AAP_ITA questionnaire]. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Periodontal Diseases, Periodontitis
How many people
495 participants
Where
No sites listed yet
Study dates
Apr 2026to Jan 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients waiting in the waiting area of the participating clinical centers without a specific chief complaint.

Who may be able to join

  • age ≥18 years;
  • ability to read and understand Italian;
  • willingness to participate in the study

Who cannot join

  • completely edentulous individuals;
  • subjects who have taken antibiotics within the past 3 months;
  • pregnant women;
  • individuals with contraindications to periodontal probing

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Leonardo Trombelli, principal investigator contact

+39 0532 688506

leonardo.trombelli@unife.it

About this study

Official title: Sviluppo, Validazione e Determinazione Della Accuratezza Diagnostica di un Questionario Per lo Screening di Parodontite

The present study aims at validating the Italian version of one of the most widely used epidemiological questionnaires for periodontitis screening: the CDC/AAP questionnaire [hereafter referred to as the CDC/AAP_ITA questionnaire].

The study also aims to develop a modified version of the CDC/AAP questionnaire, enriched with additional questions, and to evaluate its diagnostic accuracy [hereafter referred to as the QSIdP questionnaire].

The study will be conducted at the Unità Complessa di Odontoiatria, Azienda Unità Sanitaria Locale (A.U.S.L.) of Ferrara (Director: Prof. Leonardo Trombelli), in collaboration with nine (9) other Italian clinical centers.

Read the detailed description

The present multicenter cross-sectional clinical study aims at validateing the Italian version of one of the most widely used epidemiological questionnaires for periodontitis screening: the CDC/AAP questionnaire [hereafter referred to as CDC/AAP_ITA]. Furthermore, the study aims at developing a modified version of the CDC/AAP_ITA questionnaire, enriched with additional questions, and to assess its diagnostic accuracy [hereafter referred to as QSIdP].

All procedures included in the study protocol will be conducted in full compliance with the latest version of the Declaration of Helsinki. Participation in the study will require the signing of an informed consent form by each enrolled participant. In addition, the study will adhere to the STARD (Standards for Reporting Diagnostic Accuracy) guidelines.

Following development and validation, the CDC/AAP_ITA questionnaire (consisting of 8 questions) and the QSIdP questionnaire (consisting of 10 questions) will be administered to 495 patients with heterogeneous periodontal conditions recruited from ten Italian university clinical centers and/or public health facilities. Among these, Unità Complessa di Odontoiatria, Azienda Unità Sanitaria Locale (A.U.S.L.) of Ferrara (Director: Prof. Leonardo Trombelli), will be the Coordinating Center.

Within each center, patients will be enrolled according to specific inclusion criteria (i.e., age ≥18 years, ability to read and understand Italian, willingness to participate in the study) and exclusion criteria (i.e., completely edentulous individuals, subjects who have taken antibiotics within the past 3 months, pregnant women, or individuals with contraindications to periodontal probing).

Patient selection will take place during their stay in the waiting area of each participating clinical center, regardless of their chief complaint. Therefore, the questionnaires will be administered to all first-visit patients (and not exclusively to those seeking periodontal assessment).

Participants enrolled in the study will be asked to complete both the CDC/AAP_ITA and QSIdP questionnaires without external assistance. Each questionnaire will be identified by an alphanumeric code composed of the center's identifier and a progressive number. Only the principal investigator at each clinical center will hold the list linking patient names to their corresponding alphanumeric codes, thereby ensuring complete data de-identification.

Upon completion of the CDC/AAP_ITA and QSIdP questionnaires, participants will undergo a full-mouth periodontal clinical examination aimed at recording the following clinical parameters: probing depth (PD), clinical attachment level (CAL), and bleeding on probing (BoP%). Demographic information (age, sex, body mass index), medical history (diabetes, other systemic diseases), and smoking habits will be retrieved from the patient's clinical record. In cases where this information is missing or outdated (more than six months), it will be reconfirmed with the patient. When available, radiographic information will also be integrated into the clinical data.

The clinician responsible for recording clinical parameters will then formulate a periodontal diagnosis according to two different classification systems:

  1. Page \& Eke, the reference standard for epidemiological studies; and ii) Tonetti et al. case definition for periodontitis.

The association between self-reported measures of periodontal disease (derived from the questionnaires) and clinical diagnosis (derived from the periodontal examination) will be analyzed using logistic regression models adjusted for potential patient-specific confounders.

Keywords
diagnosis, self-reported questionnaire, validation, sensitivity, specificity
Medical subject headings
Periodontal Diseases, Periodontitis, Disease, Hypersensitivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07461753
Study groupRoleWhat they receive
Patients receiving "CDC/AAP_ITA" and "QSIdP" questionnairePatients enrolled in the study (and belonging the unique examined study group) will receive the "CDC/AAP_ITA" and "QSIdP" questionnaires while waiting in the waiting room of one of the Clinical Centers. They will be instructed to complete the questionnaires independently and without assistance.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Specificity

    questionnaire ability to correctly reject healthy patients without a condition

    Measured: baseline visit

  2. sensitivity

    questionnaire ability to correctly detect ill patients out of those who do have the condition

    Measured: baseline vist

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Mar 2026
  2. Study startApr 2026 (estimated)
  3. Primary completionSep 2026 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
495 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07461753
Sponsor's protocol ID
532/2025/Oss/AUSLFe
Acronym
Q_ITA
Status last verified
Oct 2025
First submitted
2 Mar 2026
Last updated
10 Mar 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Montero E, La Rosa M, Montanya E, Calle-Pascual AL, Genco RJ, Sanz M, Herrera D. Validation of self-reported measures of periodontitis in a Spanish Population. J Periodontal Res. 2020 Jun;55(3):400-409. doi: 10.1111/jre.12724. Epub 2019 Dec 24.

    PubMed 31872881
  • Carra MC, Gueguen A, Thomas F, Pannier B, Caligiuri G, Steg PG, Zins M, Bouchard P. Self-report assessment of severe periodontitis: Periodontal screening score development. J Clin Periodontol. 2018 Jul;45(7):818-831. doi: 10.1111/jcpe.12899. Epub 2018 May 16.

    PubMed 29611224
  • Deng K, Pelekos G, Jin L, Tonetti MS. Diagnostic accuracy of self-reported measures of periodontal disease: A clinical validation study using the 2017 case definitions. J Clin Periodontol. 2021 Aug;48(8):1037-1050. doi: 10.1111/jcpe.13484. Epub 2021 Jun 1.

    PubMed 33998009
  • Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Clin Periodontol. 2018 Jun;45 Suppl 20:S149-S161. doi: 10.1111/jcpe.12945.

    PubMed 29926495
  • Eke PI, Genco RJ. CDC Periodontal Disease Surveillance Project: background, objectives, and progress report. J Periodontol. 2007 Jul;78(7 Suppl):1366-71. doi: 10.1902/jop.2007.070134.

    PubMed 17610396

Questions about this trial

What is this clinical trial studying?

An observational study of Periodontal Diseases and Periodontitis, run by Azienda Unità Sanitaria Locale (A.U.S.L.) Ferrara, Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 10 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Leonardo Trombelli, principal investigator (+39 0532 688506, leonardo.trombelli@unife.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Specificity (time frame: baseline visit). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07461753, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in